Bajelot, Dwyane Derrick Jim M.

HRN: 19-66-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFUROXIME 750MG (VIAL)
10/21/2022
10/28/2022
IV
300mg
Q8h
Pcap C
Waiting Final Action 
06/24/2023
CEFUROXIME 750MG (VIAL)
06/24/2023
07/01/2023
IV
340mg
Q8
PCAP C
Waiting Final Action 
06/24/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/24/2023
07/01/2023
PO
4.5ml
TID
Ameobiasis
Waiting Final Action 
06/26/2023
CEFTRIAXONE 1G (VIAL)
06/26/2023
07/02/2023
IV
1g
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: